S100A7 and breast cancer: Similar to SUM159 breast cancer cells, we discovered that treatment of LPS blocker (PMB) reduced the LPS‐mediated expression of S100A7 in S100A7‐overexpressing MDA‐MB‐231 cells (Fig. 6C).